Multimedia
YEAR IN REVIEW DIGITAL ISSUE
VIDEOS
Sustained Joint and Skin Improvement Found With Bimekizumab in Psoriatic Arthritis
Christopher T. Ritchlin, MD, MPH, discusses updated bimekizumab data from the BE-ACTIVE trial.
Novel, Intra-articular Wnt Pathway Inhibitor May Improve Knee Osteoarthritis
Yusuf Yazici, MD, discusses results from a trial evaluating a small molecule inhibitor of the Wnt pathway for the treatment of knee osteoarthritis.
Updated Baricitinib Safety Data Available for Active Rheumatoid Arthritis
Terence Rooney, MD, senior medical director, Lilly Bio-Medicines, discusses updated baricitinib safety data presented at ACR/ARHP 2018.
Pregnancy in Inflammatory Arthritis: What Your Patients Need to Know
Megan Clowse, MD, MPH, discusses 2 studies that examine reproductive health concerns in women with inflammatory rheumatic diseases.
Inhibition of the Wnt Pathway: Potential Benefits for Osteoarthritis
Allan Gibofsky, MD, discusses inhibition of the Wnt pathway and its potential benefits for the treatment of osteoarthritis.
SLIDESHOWS
Uncommon Mimickers of Systemic Lupus Erythematosus
—————————————————————————————————————————————————————— Systemic lupus erythematosus (SLE) can be associated with many diagnostic challenges. Although SLE was first recognized as a systemic disease more than a century ago,1 there is still no definitive test for this complex, multisystemic, autoimmune disease.2 Instead, SLE is diagnosed based on a battery of clinical features and laboratory test results, none of…
Skeletal Complications in Rheumatoid Arthritis: A Comprehensive Review
Patients with RA often experience progressive bone loss and erosion, culminating in poor skeletal health and manifestations such as joint and spinal ankylosis, osteoporosis, and fracture.
Predictions in Medicine 2019: What’s Ahead
What breakthroughs in medicine do experts expect to see in 2019 and beyond?
Derm Dx: Erythematous Rash on the Upper Back
A 32-year-old man is referred for evaluation of an erythematous rash on his upper back that has been present for approximately 2 months. At age 25, he was diagnosed with systemic lupus erythematosus (SLE), a disease that also affects his mother. Treatment with hydroxychloroquine 200 mg/d was restarted approximately 1 month ago. Examination reveals annular,…
Examining the Spectrum of Neurologic Manifestations in Antiphospholipid Syndrome
Many patients with antiphospholipid syndrome develop neurological disorders that appear to have a nonthrombotic pathogenesis.
CLINICAL QUIZZES
Want to read more?
Please login or register first to view this content.